Advanced search
Start date
Betweenand

Xanthomonas citri subs. citri, causal agent of Citrus canker: molecular epidemiology and assessment of lytic bacteriophage as Biocontrol agents

Grant number: 17/50454-9
Support type:Regular Research Grants
Duration: July 01, 2018 - June 30, 2019
Field of knowledge:Agronomical Sciences - Agronomy
Cooperation agreement: BBSRC, UKRI ; Newton Fund, with FAPESP as a partner institution in Brazil
Principal Investigator:Henrique Ferreira
Grantee:Henrique Ferreira
Principal investigator abroad: Mark Charles Enright
Institution abroad: Manchester Metropolitan University (MMU), England
Home Institution: Instituto de Biociências (IB). Universidade Estadual Paulista (UNESP). Campus de Rio Claro. Rio Claro , SP, Brazil

Abstract

Asiatic Citrus Canker (ACC) is a serious, untreatable infection of citrus trees that threatens sweet orange production in the state of Sao Paulo - a key industry economically. ACC is caused by the bacterium Xanthomonas citri subsp. citri. Infection with this organism necessitates removal and destruction of infected trees and prevention measures typically rely on the use of spraying with environmentally harmful copper bactericides. I this project we will examine the current genetic diversity of X. citri from infected plants in Sao Paulo using whole genome sequencing. This will allow us to study how the pathogen is spreading in an endemic situation - after the changes in legislation allowing the presence of the bacterium in the orchards. This information will give us important knowledge regarding its population biology. In this project, we will also isolate and characterize X. citri specific viruses (known as bacteriophage). Bacteriophages are proposed as an alternative to antibiotics in human health and they are currently used in the food industry eg for controlling Listeria contamination in cheese production. They are also used in the control of bacterial infections in tomato and pepper crops in the United States. We will isolate and characterize a large collection of bacteriophage from infected plant material to assess their suitability for use in biocontrol of ACC. This initial pump-priming proposal will be developed in years two and three to include in vitro infection studies in greenhouse using bacteriophages as treatments or protective agents. We will also investigate bacteriophage host-binding structures as possible species-specific ligands for delivery of antimicrobial. (AU)